Page 96 - MONOGRAFIA 25, de Esclerosis multiple
P. 96

 FACTORES AMBIENTALES
DE LA ESCLEROSIS MÚLTIPLE
96
15. Boursi B, Werner TJ, Gholami S, Houshmand S, Mamtani R, Lewis JD, et al. Functional imaging of the interaction between gut microbiota and the human host: a proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT. PLoS One. 2018 Feb 15;13(2):e0192747. Disponible en: http://dx.plos.org/10.1371/journal.pone.0192747.
16. Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut. 2013 Nov;62(11):1591-601. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23236009.
17. Blaser MJ. The theory of disappearing microbiota and the epidemics of chronic diseases. Nat Rev Immunol. 2017 Jul 27;17(8):461-3. Disponible en: http://www.ncbi.nlm.nih.gov/ pubmed/28749457.
18. Pröbstel AK, Baranzini SE. The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the “MS Microbiome”. Neurotherapeutics. 2017 Nov 16;15(1):126-34. Disponible en: http://link.springer.com/10.1007/s13311-017-0587-y.
19. Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, et al. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med. 2015 Jun;63(5):729- 34. Disponible en: http://jim.bmj.com/lookup/doi/10.1097/JIM.0000000000000192.
20. Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One. 2015 Jan;10(9):e0137429. Disponible en: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=4569432&tool=pmcentrez&rendertype=abstract.
21. Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Soldan MMP, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016 Sep 27;6(1):28484. Disponible en: http://www.nature.com/articles/srep28484.
22. Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016 Jun 28;7:12015. Disponible en: http:// www.nature.com/doifinder/10.1038/ncomms12015.
23. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, et al. Gut microbiota composition and relapse risk in pediatric MS: A pilot study. J Neurol Sci. 2016 Apr;363:153-7. Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S0022510X16301071.
24. Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10713-8. Disponible en: http://www.pnas.org/ lookup/doi/10.1073/pnas.1711235114.
25. Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10719-24. Disponible en: http://www.pnas.org/lookup/doi/10.1073/ pnas.1711233114.
26. Dopkins N, Nagarkatti PS, Nagarkatti M. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology. 2018 Feb 2. Disponible en: http://doi.wiley.com/10.1111/imm.12903.
27. Berer K, Mues M, Koutrolos M, Rasbi Z Al, Boziki M, Johner C, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011 Nov 26;479(7374):538-41. Disponible en: http://www.nature.com/articles/nature10554.
  


















































































   94   95   96   97   98